Variant report
Variant | esv2763916 |
---|---|
Chromosome Location | chr5:29077389-29078634 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6450669 | chr5:29077428-29077429 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs142154347 | chr5:29077449-29077450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557924929 | chr5:29077462-29077463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs6450670 | chr5:29077468-29077469 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs4340931 | chr5:29077470-29077471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs79563884 | chr5:29077514-29077515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs565921561 | chr5:29077568-29077569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537178446 | chr5:29077605-29077606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs376131908 | chr5:29077620-29077621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573335783 | chr5:29077638-29077639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs115601092 | chr5:29077648-29077649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs562287293 | chr5:29077671-29077672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs151187901 | chr5:29077694-29077695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546087489 | chr5:29077716-29077717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs564653639 | chr5:29077756-29077757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs72741088 | chr5:29077765-29077766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs824326 | chr5:29077782-29077783 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs824327 | chr5:29077827-29077828 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs529336362 | chr5:29077829-29077830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs550990941 | chr5:29077836-29077837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs569415082 | chr5:29077856-29077857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529400670 | chr5:29077863-29077864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546187998 | chr5:29077890-29077891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs374890431 | chr5:29077938-29077939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs824328 | chr5:29077957-29077958 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs566623861 | chr5:29078000-29078001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533730890 | chr5:29078012-29078013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs190765792 | chr5:29078020-29078021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539024729 | chr5:29078047-29078048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs34600673 | chr5:29078048-29078049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs567220198 | chr5:29078065-29078066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs824329 | chr5:29078099-29078100 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs374863355 | chr5:29078109-29078110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs80351370 | chr5:29078115-29078116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181686743 | chr5:29078134-29078135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs62353941 | chr5:29078173-29078174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs140998321 | chr5:29078191-29078192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542090672 | chr5:29078208-29078209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs371908809 | chr5:29078260-29078261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs573420311 | chr5:29078276-29078277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186273100 | chr5:29078277-29078278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562418629 | chr5:29078295-29078296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs76796166 | chr5:29078315-29078316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs569616495 | chr5:29078321-29078322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544628127 | chr5:29078380-29078381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs562825528 | chr5:29078384-29078385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533290033 | chr5:29078385-29078386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Bipolar disorder | 19114987 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29077400-29078000 | Enhancers | A549 | lung |
2 | chr5:29077400-29078400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr5:29077400-29078400 | Enhancers | Hela-S3 | cervix |
4 | chr5:29077600-29078000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |